OncoSec Medical Inc (ONCSQ)

[hschlauch]

There is what I believe to be a significant catalyst coming up this month. If you look at the recent 10q from June along with the March news release, there should be some extension data for the phase 2 advanced melanoma trial coming out very soon. These data - along with the OMS-I100 data - will inform their proposed combination registration trial for advanced melanoma.

They are testing two different treatment regimens, both of which require more frequent IL-12 treatments.